These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28018925)

  • 21. Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
    Mhamilawa LE; Ngasala B; Morris U; Kitabi EN; Barnes R; Soe AP; Mmbando BP; Björkman A; Mårtensson A
    Malar J; 2020 Jun; 19(1):216. PubMed ID: 32576258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and Safety Profile of Artesunate-Amodiaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults.
    Banda CG; Dzinjalamala F; Mukaka M; Mallewa J; Maiden V; Terlouw DJ; Lalloo DG; Khoo SH; Mwapasa V
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.
    Lefèvre G; Carpenter P; Souppart C; Schmidli H; McClean M; Stypinski D
    Br J Clin Pharmacol; 2002 Nov; 54(5):485-92. PubMed ID: 12445027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Pregnancy on the Pharmacokinetic Interaction between Efavirenz and Lumefantrine in HIV-Malaria Coinfection.
    Adegbola A; Abutaima R; Olagunju A; Ijarotimi O; Siccardi M; Owen A; Soyinka J; Bolaji O
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
    Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A randomized clinical trial comparing the effectiveness and tolerability of artemisinine-naphthoquine (Arco®) and artemether-lumefantrine (Coartem®) in the treatment of uncomplicated malaria in Benin].
    Kinde-Gazard D; Ogouyèmi-Hounto A; Capo-Chichi L; Gbaguidi J; Massougbodji A
    Bull Soc Pathol Exot; 2012 Aug; 105(3):208-14. PubMed ID: 22328063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of nevirapine, efavirenz and lopinavir/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria.
    Usman SO; Oreagba IA; Akinyede AA; Agbaje EO; Akinleye MO; Onwujuobi AG; Ken-Owotor C; Adeuja O; Ogunfowokan T; Kogbe S; Owolabi ET; Adeniji H; Busari AW; Hassan OO; Abideen G; Akanmu AS
    J Pharmacol Sci; 2020 Nov; 144(3):95-101. PubMed ID: 32921396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative pharmacokinetics and pharmacodynamics of intravenous artelinate versus artesunate in uncomplicated Plasmodium coatneyi-infected rhesus monkey model.
    Teja-Isavadharm P; Siriyanonda D; Rasameesoraj M; Limsalakpeth A; Chanarat N; Komcharoen N; Weina PJ; Saunders DL; Gettayacamin M; Scott Miller R
    Malar J; 2016 Sep; 15(1):453. PubMed ID: 27599723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.
    Gasasira AF; Kamya MR; Achan J; Mebrahtu T; Kalyango JN; Ruel T; Charlebois E; Staedke SG; Kekitiinwa A; Rosenthal PJ; Havlir D; Dorsey G
    Clin Infect Dis; 2008 Apr; 46(7):985-91. PubMed ID: 18444813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug.
    Bakshi R; Hermeling-Fritz I; Gathmann I; Alteri E
    Trans R Soc Trop Med Hyg; 2000; 94(4):419-24. PubMed ID: 11127248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics of artemether-lumefantrine influence on nevirapine disposition: Clinically significant drug-drug interaction?
    Abdullahi ST; Olagunju A; Soyinka JO; Bolarinwa RA; Olarewaju OJ; Bakare-Odunola MT; Owen A; Khoo S
    Br J Clin Pharmacol; 2019 Mar; 85(3):540-550. PubMed ID: 30471138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
    Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
    Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether.
    Watson DJ; Laing L; Gibhard L; Wong HN; Haynes RK; Wiesner L
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0099021. PubMed ID: 34097488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults.
    Byakika-Kibwika P; Lamorde M; Lwabi P; Nyakoojo WB; Okaba-Kayom V; Mayanja-Kizza H; Boffito M; Katabira E; Back D; Khoo S; Merry C
    Chemother Res Pract; 2011; 2011():393976. PubMed ID: 22312553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.
    Whalen ME; Kajubi R; Goodwin J; Orukan F; Colt M; Huang L; Richards K; Wang K; Li F; Mwebaza N; Aweeka FT; Parikh S
    Clin Infect Dis; 2023 Feb; 76(3):443-452. PubMed ID: 36130191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong correlation of lumefantrine concentrations in capillary and venous plasma from malaria patients.
    Huang L; Mwebaza N; Kajubi R; Marzan F; Forsman C; Parikh S; Aweeka FT
    PLoS One; 2018; 13(8):e0202082. PubMed ID: 30114201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children.
    Kajubi R; Huang L; Were M; Kiconco S; Li F; Marzan F; Gingrich D; Nyunt MM; Ssebuliba J; Mwebaza N; Aweeka FT; Parikh S
    Open Forum Infect Dis; 2016 Oct; 3(4):ofw217. PubMed ID: 28018925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
    Hughes E; Mwebaza N; Huang L; Kajubi R; Nguyen V; Nyunt MM; Orukan F; Mwima MW; Parikh S; Aweeka F
    J Acquir Immune Defic Syndr; 2020 Feb; 83(2):140-147. PubMed ID: 31929402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
    Huang L; Carey V; Lindsey JC; Marzan F; Gingrich D; Graham B; Barlow-Mosha L; Ssemambo PK; Kamthunzi P; Nachman S; Parikh S; Aweeka FT;
    PLoS One; 2017; 12(10):e0186589. PubMed ID: 29065172
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.